NCT00904800View on ClinicalTrials.gov

AZD0837 Extended Release (ER) Japan Study

PHASE1CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

May 31, 2009

Study Completion Date

June 30, 2009

Conditions

Healthy

Interventions

DRUG

AZD0837

tablet, oral, once daily, 1+5 days

DRUG

Placebo

Placebo

Trial Locations (1)

Unknown

Research Site, Kagoshima

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY